Platelet PDGF and TGF-β Levels in Myeloproliferative Disorders

References

• Jacobson R. J., Salo A., Fialkow P. J. Agnonic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis. Blood 1978; 51: 189–194
   PubMed Web of Science ®Google Scholar
• Buschle M., Janssen J. W. G., Dexler H., Lyons J., Anger B., Bartram C. R. Evidence for pluripotent stem cell origin of myelofibrosis: clonal analysis of a case characterized by a N-ras gene mutation. Leukemia 1988; 2: 658–660
   PubMed Web of Science ®Google Scholar
• Rosenthal D. S., Maloney W. B. Myeloid metaplasia: a study of 98 cases. Postgrad. Med 1969; 45: 136–142
   PubMed Web of Science ®Google Scholar
• Kimura A., Fujimoto T., Inada T., Imamura N., Oguma N., Kajihara H., Mtasiwa D. M., Katoh O., Fujimura K., Kuramoto A. Blastic transformation in essential thrombocythemia. In vitro differentiation of blast cells into granulocytic, erythroid, and megakaryocytic lineages. Cancer 1990; 65: 1538–1544
   PubMed Web of Science ®Google Scholar
• Najean Y., Deschamps A., Dresh C., Daniel M. T., Rain J. D., Arrago J. P. Acute leukemia and myelodysplasia in polycythemia vera. A clinical study with long-term follow up. Cancer 1988; 58: 2440–2447
   Google Scholar
• Castro-Malaspina H., Gay R. E., Jhanwar S. C., Hamilton J. A., Chiarieri D. R., Meyers P. A., Gay S., Moore M. A. S. Characteristics of bone marrow fibroblasts colony-forming cells (CFU-F) and their progeny in patients with myeloproliferative disorders. Blood 1982; 59: 1046–1054
   PubMed Web of Science ®Google Scholar
• Groopman J. E. The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann. Internal Med 1980; 92: 857–858
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H., Rabellino E. M., Yen A., Nachman R. L., Moore M. A. S. Human megakaryocyte stimulation of proliferation of bone marrow fibroblasts. Blood 1981; 57: 781–787
   PubMed Web of Science ®Google Scholar
• Hibbin J. A., Njoku O. S., Matutes E., Lewis S. M., Goldman J. M. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br. J. Haematol 1984; 57: 495–503
   PubMed Web of Science ®Google Scholar
• Castro-Malaspina H. Pathogenesis of myelofibrosis: role of ineffective megakaryopoiesis and megakaryocyte components. Myelofibrosis and the Biology of Connective Tissue. Alan R. Liss, Inc. 1984; 427–454
   Google Scholar
• Thiele J., Kuemmel T., Sander C., Fischer R. Ultrastructure of bone marrow tissue in so-called primary (idiopathic) myelofibrosis—osteomyelosclerosis (agnogenic myeloid metaplasia). I. Abnormalities of megakaryopoiesis and thrombocytes. J. Submicrosc. Cytol. Pathol 1991; 23: 93–107
   PubMed Web of Science ®Google Scholar
• Baker R. I., Manoharan A. Platelet function in myeloproliferative disorders: characterization and sequential studies show multiple platelet abnormalities, and change with time. Eur. J. Haematol 1988; 40: 267–272
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Hyodo H., Kuramoto A. Transforming growth factor-β regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. Br. J. Haematol 1989; 72: 486–491
   PubMed Web of Science ®Google Scholar
• Kimura A., Katoh O., Kuramoto A. Effects of platelet derived growth factor, epidermal growth factor and transforming growth factor-β on the growth of human marrow fibroblasts. Br. J. Haematol 1988; 69: 9–12
   PubMed Web of Science ®Google Scholar
• Bentley S. A. Biology and pathology of bone marrow connective tissue. Myelofibrosis, Pathophysiology and Clinical Management, S. M. Lewis. Marcel Dekker, New York 1983; 87–96
   Google Scholar
• Ross R., Raines E. W., Bowen-Pope D. F. The biology of platelet-derived growth factor. Cell 1986; 46: 155–169
   PubMed Web of Science ®Google Scholar
• Hammacher A., Hellman U., Johnsson A. A., Ostman A., Gunnarsson K., Westermark B., Wasteson A., Heldin C. H. A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J. Biol. Chem 1988; 263: 16493–16498
   PubMed Web of Science ®Google Scholar
• Nister M., Hammacher A. A., Mellström K., Siegbahn A., Rönnstrand L., Westermark B., Heldin C. H. A glioma-derived PDGF A chain homodimer has different functional activities from a PDGF AB heterodimer purified from human platelets. Cell 1988; 52: 791–799
   PubMed Web of Science ®Google Scholar
• Bernabei P., Arcangeli A., Casini M., Grossi A., Padovani R., Rossi Ferrini P. Platelet-derived growth factor(s) mitogenic activity in patients with myeloproliferative disease. Br. J. Haematol 1986; 63: 353–357
   PubMed Web of Science ®Google Scholar
• Katoh O., Kimura A., Kuramoto A. Platelet-derived growth factor is decreased in patients with myeloproliferative disorders. Am. J. Haematol 1988; 27: 276–280
   PubMed Web of Science ®Google Scholar
• Romano M., Poggi A., Donati M. B., Cortelazzo S., Viero P., Barbui T. Reduced platelet mitogenic activity in myeloproliferative disorders. Lancet 1986; ii: 345
   Google Scholar
• Romano M., Viero P., Cortellazzo S., Barbui T., Donati M. B., Poggi A. Platelet-derived mitogenic activity and bone-marrow fibrosis in myeloproliferative disorders. Haemostasis 1990; 20: 162–168
   PubMedGoogle Scholar
• Rueda F., Pinol G., Marti F., Pujol-Moix N. Abnormal levels of platelet-specific proteins and mitogenic activity in myeloproliferative disease. Acta Haematol 1991; 85: 12–15
   PubMed Web of Science ®Google Scholar
• Caligaris-Cappio F., Vigliani R., Novarino A. Idiopathic myelofibrosis: a possible role for immune-complexes in the pathogenesis of bone marrow fibrosis. Br. J. Haematol 1981; 49: 17–23
   PubMed Web of Science ®Google Scholar
• Baglin T. P., Simpson A. W., Price S. M., Boughton B. J. The composition of immune complexes and their relationship to plasma fibronectin in chronic myeloproliferative disorders. J. Clin. Pathol 1987; 40: 1468–1471
   PubMed Web of Science ®Google Scholar
• Baglin T. P., Price S. M., Boughton B. J. A reversible defect of platelet PDGF content in myeloproliferative disorders. Br. J. Haematol 1988; 69: 483–486
   PubMed Web of Science ®Google Scholar
• Gersyuk G. M., Carmel R., Pattengale P. K. Platelet-derived growth factor concentration in platelet-poor plasma and urine from patients with myeloproliferative disorders. Blood 1989; 74: 2330–2334
   PubMed Web of Science ®Google Scholar
• Caenazzo A., Pietrogrande F., Polato G., Piva E., Masiero M., Sgarabotto D., Girolami A. Changes in the mitogenic activity of platelet-derived growth factor(s) in patients with myeloproliferative disease. Acta Haematol 1989; 81: 131–135
   PubMed Web of Science ®Google Scholar
• Martyré M. C., Magdelenat H., Bryckaert M. C, Laine-Bidron C., Calvo F. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br. J. Haematol 1991; 77: 80–86
   PubMed Web of Science ®Google Scholar
• Martyré M. C., Magdelenat H., Calvo F. Interferon-γ in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-β in patients with myelofibrosis with myeloid metaplasia. Br. J. Haematol 1991; 77: 431–435
   PubMed Web of Science ®Google Scholar
• Marcus R. E., Hibbin J. A., Matutes E., Whittle N., Waterfield M. D., Goldman J. M. Megakaryoblastic transformation of myelofibrosis with expression of the c-sis oncogene. Scand. J. Haematol 1986; 36: 186–193
   PubMedGoogle Scholar
• Katoh O., Kimura A., Itoh T., Kuramoto A. Platelet-derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders. Am. J. Hematol 1990; 35: 145–150
   PubMed Web of Science ®Google Scholar
• Barnard J. A., Lyons R. M., Moses H. L. The cell biology of transforming growth factor. β. Biochim. Biophys. Acta 1990; 1032: 79–87
   PubMed Web of Science ®Google Scholar
• Ignotz R. A., Massague J. Transforming growth factor β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem 1986; 261: 4337–4345
   PubMed Web of Science ®Google Scholar
• Laiho M., Keski-Oja J. Growth factors in the regulation of pericellular proteolysis: A review. Cancer Res 1989; 49: 2533–2553
   PubMed Web of Science ®Google Scholar
• Roberts A. B., Sporn M. B., Assoian R. K., Smith J. M., Roche N. S., Wakefield L. M. Transforming growth factor β rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc. Natl. Acad. Sci. USA 1986; 83: 4167–4171
   PubMed Web of Science ®Google Scholar
• Fava R. A., Casey T. T., Wilcox J., Pelton R. W., Moses H. L., Nanney L. B. Synthesis of transforming growth factor-β1 by megakaryocytes and its localization to megakaryocyte and platelet α-granules. Blood 1990; 76: 1946–1955
   PubMed Web of Science ®Google Scholar
• Raghow R., Irish P., Kang A. H. Coordinate regulation of transforming growth factor β gene expression and cell proliferation in hamster lungs undergoing bleomycin induced pulmonary fibrosis. J. Clin. Invest 1989; 84: 1836–1842
   PubMed Web of Science ®Google Scholar
• Armendariz-Borunda J., Seyer J. M., Kang A. H., Raghow R. Regulation of TGF-β gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J 1990; 4: 215–221
   PubMed Web of Science ®Google Scholar
• Connor T. B., Roberts A. B., Sporn M. B., Danielpour D. D., Dart L. L., Michels R. G., de Bustros S., Enger C., Kato H., Lansing M., Kayashi H., Glaser B. M. Correlation of fibrosis and transforming growth factor-β type 2 levels in the eye. J. Clin. Oncol 1989; 83: 1661–1666
   Google Scholar
• Castilla A., Prieto J., Fausto N. Transforming growth factors β1 and α in chronic liver disease. Effects of interferon alfa therapy. New Engl. J. Med 1991; 324: 933–940
   PubMed Web of Science ®Google Scholar
• Terui T., Niitsu Y., Mahara K., Fujisaki Y., Urushizaki Y., Mogi Y., Kohgo Y., Watanabe N., Ogura M., Saito H. The production of transforming growth factor-β in acute megakaryoblastic leukemia and its possible implications in myelofibrosis. Blood 1990; 75: 1540–1548
   PubMed Web of Science ®Google Scholar
• Clare N., Elson D., Mannhoff L. Cytogenetic studies of peripheral myeloblasts and bone marrow fibroblasts in acute myelofibrosis. Am. J. Clin. Pathol 1982; 77: 762–766
   PubMed Web of Science ®Google Scholar